Wegovy and Zepbound prices fall, but access to the obesity drugs still isn’t guaranteed
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains…
Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs
People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s…
Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs
People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s…
Weight-loss drug Zepbound faces coverage challenge from CVS Health
Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.…
Patients struggle as compounded GLP-1 access rapidly shrinks
The explosion of compounded GLP-1 offerings over the past two years is coming to an end, and many…
Is weight loss drug Mounjaro effective? Expert reacts |
The weight loss drug market is booming. After months of anticipation, Eli Lilly’s drug Mounjaro (Tirzepatide) was also…
Novo preparing for early launch of weight-loss drug Wegovy in India
By Rishika Sadam HYDERABAD (Reuters) – Danish drugmaker Novo Nordisk is looking at an early launch of its…